PEComa of the Upper Extremity: A Unique Case and Initial Response to Chemotherapy
Author Information
Author(s): Osei D. A., Alvandi F., Brooks J. S., Ogilvie C. M.
Primary Institution: University of Pennsylvania School of Medicine
Hypothesis
Can neoadjuvant chemotherapy improve outcomes in patients with PEComa?
Conclusion
The treatment regimen used in this case may provide a promising starting point for neoadjuvant therapy in PEComa, despite the tumor's historically poor prognosis.
Supporting Evidence
- The tumor showed an 80% reduction in size after six cycles of chemotherapy.
- The patient had no local recurrence for 21 months after treatment.
- Pathology revealed only 20% necrosis in the tumor after resection.
Takeaway
A woman with a rare tumor in her arm got better after chemotherapy, which is usually not effective for this type of tumor.
Methodology
The patient received neoadjuvant chemotherapy with doxorubicin and ifosfamide followed by radiation therapy before surgical resection.
Limitations
The study is based on a single case report, limiting generalizability.
Participant Demographics
A 49-year-old female patient.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website